Drug Profile
Sofinicline
Alternative Names: A-422894.0; ABT-894Latest Information Update: 23 Jan 2013
Price :
$50
*
At a glance
- Originator Abbott Laboratories; NeuroSearch
- Developer Abbott Laboratories
- Class Analgesics
- Mechanism of Action Alpha4beta2 nicotinic receptor modulators; Nicotinic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes
Highest Development Phases
- No development reported Attention-deficit hyperactivity disorder; Cognition disorders
- Discontinued Diabetic neuropathies